Immunic

$17.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.17 (+0.98%) Today

$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Immunic and other stocks, options, and ETFs commission-free!

About IMUX

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA. The listed name for IMUX is Immunic, Inc. Common Stock.

CEO

Daniel Vitt

Employees

Headquarters

New York, New York

Founded

—

Market Cap

363.61M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

403.68K

High Today

$17.63

Low Today

$17.18

Open Price

$17.46

Volume

117.21K

52 Week High

$23.39

52 Week Low

$4.19

Collections

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

IMUX Earnings

-$1.52

-$1.01

-$0.51

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 16, After Hours